Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

ALNAQ Allena Pharmaceuticals

Watchlist
0.0020.0000.00%
Close  02/03 16:00 ET
High
0.002
Open
0.002
Turnover
241.54
Low
0.002
Pre Close
0.002
Volume
120.77K
Market Cap
244.17K
P/E(TTM)
Loss
52wk High
0.550
Shares
122.08M
P/E(Static)
Loss
52wk Low
0.000
Float Cap
241.93K
Bid/Ask %
0.00%
Historical High
17.560
Shs Float
120.96M
Volume Ratio
2.07
Historical Low
0.000
Dividend TTM
--
Div Yield TTM
--
P/B
0.06
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.10%
Amplitude
0.00%
Avg Price
0.002
Lot Size
1
Float Cap
241.93K
Bid/Ask %
0.00%
Historical High
17.560
Shs Float
120.96M
Volume Ratio
2.07
Historical Low
0.000
Dividend TTM
--
P/B
0.06
Dividend LFY
--
Turnover Ratio
0.10%
Amplitude
0.00%
Avg Price
0.002
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Allena Pharmaceuticals, Inc. engages in the development, discovery, and commercialization of oral enzyme therapeutics to treat patients with kidney disorders. Its product pipeline includes reloxaliase, an oral enzyme therapeutic for the treatment of enteric hyperoxaluria in adults and ALLN-346, which is used for patients with hyperuricemia and moderate to severe chronic kidney disease. The company was founded by Robert Gallotto and Alexey L. Margolin on June 24, 2011 and is headquartered in Sudbury, MA.
CEO: Dr. Louis Brenner,M.D.
Market: Pink Market
Listing Date: 11/02/2017
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist